Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-12-20
1994-03-15
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 9, 514 15, A61K 3702, C07K 706, C07K 512
Patent
active
052946045
ABSTRACT:
The present invention provides a method of treating ocular diseases by the administration of cyclosporine A or G by periocular injection in a pharmaceutically acceptable carrier.
REFERENCES:
patent: 4649047 (1987-03-01), Kaswan
patent: 4839342 (1989-06-01), Kaswan
Nussenblatt et al, "Immunohistologic Findings and . . . ," Amer. J. of Ophthalmology, 107:160-166, Feb. 1989.
Nussenblatt et al, "A Comparison of the Effectiveness . . . ," J. of Immunopharmacology, 8(3), (1986), pp. 427-435.
Nussenblatt Robert B.
Palestine Alan G.
Cashion Jr. Merrell C.
Marshall S. G.
The Government of the United States of America as represented by
LandOfFree
Method of treating ocular diseases by periocular administration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating ocular diseases by periocular administration , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating ocular diseases by periocular administration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1536118